サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439284

経カテーテル塞栓・閉塞デバイス - 世界市場の考察、競合情勢、市場予測（2030年）

Transcatheter Embolization And Occlusion Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
経カテーテル塞栓・閉塞デバイス - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経カテーテル塞栓・閉塞デバイスの市場規模は、2023年に40億4,000万米ドル、2030年までに68億4,000万米ドルに達し、2024年～2030年の予測期間にCAGRで9.14％の成長が見込まれます。経カテーテル塞栓・閉塞デバイスの需要の主な要因は、技術の進歩、心血管疾患、呼吸器疾患、がんなどの慢性疾患の急増、高度に構造化された医療産業、低侵襲手術の採用の増加、老年人口の増加などです。

経カテーテル塞栓・閉塞デバイスの市場力学

経カテーテル塞栓・閉塞デバイス市場は、世界中でがん、心血管疾患などの慢性疾患の負担の増大により、大幅に成長しています。例えば、世界保健機関（WHO）（2022）のデータによると、2020年に世界で乳がん226万件、肺がん221万件、大腸がん193万件、前立腺がん141万件、胃がん109万件が報告されています。

GLOBOCANのデータによると、2020年に世界中で約1,930万人の新たながん患者が報告され、この数は2040年までに3,020万人に増加すると予測されています。

また、British Heart Foundation（2022）が提供したデータによると、2019年に全世界で約5億5,000万人、つまり14人に1人が心臓および循環器系の疾患を抱えており、これには約2億9,000万人の女性と約2億6,000万人の男性が含まれています。

経カテーテル塞栓・閉塞デバイスは、さまざまな慢性疾患に罹患している患者の治療に多く採用されているため、慢性疾患の症例の急増は、世界の経カテーテル塞栓・閉塞デバイス市場の成長に寄与します。

また、開腹手術に代わる治療法として、組織痛を最小限に抑え、切開創を小さくすることができるため、これらのデバイスの採用が増加しており、世界の経カテーテル塞栓・閉塞デバイス市場を押し上げる可能性が高いです。

さらに、ほとんどの診断研究所や病院は、新技術や優れたインフラ施設を備えています。その主たる目的は、アクセスや精度を向上させ、コストを削減することです。

高い製品コスト、熟練した医師の必要性、製品の商業化に対する厳格な規制システムの存在などの特定の要因は、経カテーテル塞栓・閉塞デバイス市場の成長を妨げる可能性があります。

経カテーテル塞栓・閉塞デバイス市場のセグメント分析

経カテーテル塞栓・閉塞デバイス市場のタイプセグメントでは、コイルカテゴリにおいて、プッシャブルコイルが2022年に世界の経カテーテル塞栓・閉塞デバイス市場の大半を占めると予測されます。この製品セグメントの急成長は、これらのデバイスの利点と用途に起因しています。

プッシャブルコイルは末梢血管や内臓の血管の機械的閉塞に利用されます。費用対効果が高く、アクセスが容易で、取り扱いも比較的容易です。

プッシャブルコイルにはさまざまな用途があり、出血抑制、動脈瘤、静脈瘤、動静脈瘻などの血管病変の閉塞、非標的血管を保護するための血流再分配などがあります。

例えば、Terumo CorporationのAZUR（TM）Peripheral Hydrocoil-Pushable Peripheral Coil Systemは、末梢血管の血流速度を減少または遮断するためのものです。このデバイスは、動静脈奇形、動静脈瘻、動脈瘤、末梢血管系などの病変のインターベンショナルラジオロジー管理における使用に適応されます。

さらに、有利な償還シナリオ、これらのデバイスの採用の増加、インド、中国、ブラジルなどの発展途上国の農村地域における設備の整った新規および既存の病院や医療センターの優れた医療インフラが、この機器の市場における将来性を高めると予測されます。

したがって、上記のすべての要因が経カテーテル塞栓・閉塞デバイス市場の成長を促進すると予測されます。

当レポートでは、世界の経カテーテル塞栓・閉塞デバイス市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 経カテーテル塞栓・閉塞デバイス市場レポートのイントロダクション

第2章 経カテーテル塞栓・閉塞デバイス市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価

第3章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 経カテーテル塞栓・閉塞デバイス市場の主な要因の分析

  • 経カテーテル塞栓・閉塞デバイス市場の促進要因
    • 慢性疾患の罹患率の増加
    • 先進技術の統合
    • 投資と官民組織による資金の増加
    • 老年人口の増加
  • 経カテーテル塞栓・閉塞デバイス市場の抑制要因と課題
    • デバイスの高いコスト
    • 熟練した医師の必要性
  • 経カテーテル塞栓・閉塞デバイス市場の機会
    • 低侵襲デバイスへの選好
    • 新興国における成長機会

第5章 経カテーテル塞栓・閉塞デバイスのポーターのファイブフォース分析

第6章 経カテーテル塞栓・閉塞デバイスの市場レイアウト

  • タイプ別
    • コイル
    • 非コイル
  • 用途別
    • 末梢血管疾患
    • 腫瘍
    • 神経
    • 泌尿器
    • その他
  • エンドユーザー別
    • 病院
    • 外来手術センター
    • 診療所
  • 地域別
    • 北米の経カテーテル塞栓・閉塞デバイスの市場規模（2021年～2030年）
    • 欧州の経カテーテル塞栓・閉塞デバイスの市場規模（2021年～2030年）
    • アジア太平洋の経カテーテル塞栓・閉塞デバイスの市場規模（2021年～2030年）
    • その他の地域の経カテーテル塞栓・閉塞デバイスの市場規模（2021年～2030年）

第7章 経カテーテル塞栓・閉塞デバイスの企業と製品のプロファイル

  • Boston Scientific Corporation
  • Medtronic PLC
  • Penumbra, Inc.
  • Cook Medical Inc.
  • Edwards Lifesciences Corporation
  • Merit Medical Systems, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Kaneka Medix Corporation
  • Stryker Corporation
  • phenox GmbH
  • Braile Biomedica
  • Terumo Corporation
  • MicroPort Scientific Corporation
  • W. L. Gore & Associates, Inc.

第8章 KOLの見解

第9章 プロジェクトのアプローチ

第10章 DelveInsightのサービス内容

第11章 DelveInsightについて

第12章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcatheter Embolization and Occlusion Devices Market in Global (2021-2030)
  • Table 3: Transcatheter Embolization and Occlusion Devices Market in Global by Type (2021-2030)
  • Table 4: Transcatheter Embolization and Occlusion Devices Market in Global by Application (2021-2030)
  • Table 5: Transcatheter Embolization and Occlusion Devices Market in Global by End-User (2021-2030)
  • Table 6: Transcatheter Embolization and Occlusion Devices Market in Global by Geography (2021-2030)
  • Table 7: Transcatheter Embolization and Occlusion Devices Market in North America (2021-2030)
  • Table 8: Transcatheter Embolization and Occlusion Devices Market in the US (2021-2030)
  • Table 9: Transcatheter Embolization and Occlusion Devices Market in Canada (2021-2030)
  • Table 10: Transcatheter Embolization and Occlusion Devices Market in Mexico (2021-2030)
  • Table 11: Transcatheter Embolization and Occlusion Devices Market in Europe (2021-2030)
  • Table 12: Transcatheter Embolization and Occlusion Devices Market in France (2021-2030)
  • Table 13: Transcatheter Embolization and Occlusion Devices Market in Germany (2021-2030)
  • Table 14: Transcatheter Embolization and Occlusion Devices Market in the United Kingdom (2021-2030)
  • Table 15: Transcatheter Embolization and Occlusion Devices Market in Italy (2021-2030)
  • Table 16: Transcatheter Embolization and Occlusion Devices Market in Spain (2021-2030)
  • Table 17: Transcatheter Embolization and Occlusion Devices Market in Rest of Europe (2021-2030)
  • Table 18: Transcatheter Embolization and Occlusion Devices Market in Asia-Pacific (2021-2030)
  • Table 19: Transcatheter Embolization and Occlusion Devices Market in China (2021-2030)
  • Table 20: Transcatheter Embolization and Occlusion Devices Market in Japan (2021-2030)
  • Table 21: Transcatheter Embolization and Occlusion Devices Market in India (2021-2030)
  • Table 22: Transcatheter Embolization and Occlusion Devices Market in Australia (2021-2030)
  • Table 23: Transcatheter Embolization and Occlusion Devices Market in South Korea (2021-2030)
  • Table 24: Transcatheter Embolization and Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Transcatheter Embolization and Occlusion Devices Market Analysis in the Rest of the World (2021-2030)
  • Table 26: Transcatheter Embolization and Occlusion Devices Market in the Middle East (2021-2030)
  • Table 27: Transcatheter Embolization and Occlusion Devices Market in Africa (2021-2030)
  • Table 28: Transcatheter Embolization and Occlusion Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcatheter Embolization and Occlusion Devices Market in Global (2021-2030)
  • Figure 3: Transcatheter Embolization and Occlusion Devices Market in Global by Type (2021-2030)
  • Figure 4: Transcatheter Embolization and Occlusion Devices Market in Global by Application (2021-2030)
  • Figure 5: Transcatheter Embolization and Occlusion Devices Market in Global by End-User (2021-2030)
  • Figure 6: Transcatheter Embolization and Occlusion Devices Market in Global by Geography (2021-2030)
  • Figure 7: Transcatheter Embolization and Occlusion Devices Market in North America (2021-2030)
  • Figure 8: Transcatheter Embolization and Occlusion Devices Market in the US (2021-2030)
  • Figure 9: Transcatheter Embolization and Occlusion Devices Market in Canada (2021-2030)
  • Figure 10: Transcatheter Embolization and Occlusion Devices Market in Mexico (2021-2030)
  • Figure 11: Transcatheter Embolization and Occlusion Devices Market in Europe (2021-2030)
  • Figure 12: Transcatheter Embolization and Occlusion Devices Market in France (2021-2030)
  • Figure 13: Transcatheter Embolization and Occlusion Devices Market in Germany (2021-2030)
  • Figure 14: Transcatheter Embolization and Occlusion Devices Market in the United Kingdom (2021-2030)
  • Figure 15: Transcatheter Embolization and Occlusion Devices Market in Italy (2021-2030)
  • Figure 16: Transcatheter Embolization and Occlusion Devices Market in Spain (2021-2030)
  • Figure 17: Transcatheter Embolization and Occlusion Devices Market in Rest of Europe (2021-2030)
  • Figure 18: Transcatheter Embolization and Occlusion Devices Market in Asia-Pacific (2021-2030)
  • Figure 19: Transcatheter Embolization and Occlusion Devices Market in China (2021-2030)
  • Figure 20: Transcatheter Embolization and Occlusion Devices Market in Japan (2021-2030)
  • Figure 21: Transcatheter Embolization and Occlusion Devices Market in India (2021-2030)
  • Figure 22: Transcatheter Embolization and Occlusion Devices Market in Australia (2021-2030)
  • Figure 23: Transcatheter Embolization and Occlusion Devices Market in South Korea (2021-2030)
  • Figure 24: Transcatheter Embolization and Occlusion Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Transcatheter Embolization and Occlusion Devices Market in the Rest of the World (2021-2030)
  • Figure 26: Transcatheter Embolization and Occlusion Devices Market in the Middle East (2021-2030)
  • Figure 27: Transcatheter Embolization and Occlusion Devices Market in Africa (2021-2030)
  • Figure 28: Transcatheter Embolization and Occlusion Devices Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0074

Transcatheter Embolization and Occlusion Devices Market By Type (Coiled [Pushable Coils and Detachable Coils], and Non-Coiled [Flow Diverting Devices, Embolization Particles, Liquid Embolic, and Others]), Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Clinics), and Geography is expected to grow at a steady CAGR forecast till 2030 owing to rising technological advancement and increasing prevalence of chronic diseases

The global transcatheter embolization and occlusion devices market was valued at USD 4.04 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, to reach USD 6.84 billion by 2030. The demand for transcatheter embolization and occlusion devices is primarily attributed to the rising technological advancement, surge in the prevalence of chronic diseases like cardiovascular diseases, respiratory disorders, and cancer, highly structured healthcare industry, increased adoption of minimally invasive surgeries, and increasing geriatric population.

Transcatheter Embolization and Occlusion Devices Market Dynamics:

Transcatheter Embolization and Occlusion Devices Market has significantly increased due to the growing burden of chronic diseases such as cancer, cardiovascular, and others throughout the world. For instance, according to the data cited by the World Health Organization (WHO) 2022, worldwide around 2.26 million cases of breast, 2.21 million cases of lung, 1.93 million cases of colon and rectum, 1.41 million cases of prostate, and 1.09 million cases of stomach cancer were reported in 2020.

As per the GLOBOCAN data, around 19.3 million new cancer cases were reported around the world in 2020, and this number is expected to increase to 30.2 million people by 2040.

Also, the data provided by British Heart Foundation 2022 mentions that worldwide around 550 million which stands for 1 in 14 people were living with heart and circulatory diseases in 2019 and this includes about 290 million women and around 260 million men.

Transcatheter embolization and occlusion devices are largely employed in the treatment of patients suffering from various chronic diseases and thus, the burgeoning cases of chronic diseases will contribute to the global transcatheter embolization and occlusion devices market growth.

In addition, increased adoption of these devices as they are used in treatment as an alternative to open surgery with minimum tissue pain and smaller incisions is likely to boost the global transcatheter embolization and occlusion devices market.

Moreover, most diagnostic labs and hospitals are equipped with new techniques and better infrastructure facilities. The predominant goal is to improve access and precision, and decrease cost.

Certain factors such as the high cost of products, the requirement of skilled physicians, and the existence of a rigid regulatory system for product commercialization would hinder the growth of the transcatheter embolization and occlusion devices market.

Transcatheter Embolization and Occlusion Devices Market Segment Analysis:

Transcatheter Embolization and Occlusion Devices by Type (Coiled [Pushable Coils and Detachable Coils], and Non-Coiled [Flow Diverting Devices, Embolization Particles, Liquid Embolic, and Others]), Application (Peripheral Vascular Disease, Oncology, Neurology, Urology, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Clinics), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Transcatheter Embolization and Occlusion Devices market type segment, under the coiled category, the pushable coils are expected to hold the majority of the global transcatheter embolization and occlusion devices market in 2022. The rapid growth of this product segment can be attributed to the advantages and applications of these devices.

Pushable coils are utilized for mechanical occlusion of peripheral and visceral vessels. These are cost-effective, easily accessible, and comparatively easier to handle.

Pushable coils have various applications and these are intended for bleeding control, to occlude vascular lesions such as aneurysms, varices, and arteriovenous fistulas (AVFs), and for redistributing the blood flow to protect nontarget vessels among others.

For example, AZUR(TM) Peripheral Hydrocoil - Pushable Peripheral Coil System by Terumo Corporation is meant for reducing or blocking the rate of blood flow in vessels of the peripheral vasculature. The device is indicated for use in the interventional radiologic management of arteriovenous malformations, arteriovenous fistulae, aneurysms, and other lesions of the peripheral vasculature.

Additionally, favorable reimbursement scenarios, increasing adoption of these devices, and better healthcare infrastructure with equipped new/existing hospitals and healthcare centers in rural regions of developing countries such as India, China, Brazil, and others are expected to enhance the market potential of this equipment.

Hence, all the above-mentioned factors are expected to drive the segment growth of the transcatheter embolization and occlusion devices market.

North America is expected to dominate the Overall Transcatheter Embolization and Occlusion Devices Market:

North America is expected to dominate the overall transcatheter embolization and occlusion devices market during the forecast period. This domination is due to the rising prevalence of various chronic diseases such as cancer, cardiovascular diseases, and others coupled with improved reimbursement policies, easy accessibility, and high adoption of technological advancements owing to the rise in healthcare expenditure by the US government. Further, the United States represents the largest market worldwide supported by developed healthcare infrastructure.

The Centers for Disease Control and Prevention (CDC) 2022, estimated that about 20.1 million adults aged 20 and older had Coronary artery disease (CAD) in the US, in 2020.

The source mentioned above stated that in the United States, someone has a heart attack every 40 seconds. Every year, about 805,000 people in the United States have a heart attack. Out of these, 605,000 are a first heart attack, 200,000 happen to people who have already had a heart attack and about 1 in 5 heart attacks are silent-the damage is done, but the person is not aware of it.

The increasing number of product development activities in the region is further going to accelerate the growth transcatheter embolization and occlusion devices market. For example, in March 2022, Artio Medical, Inc. received the US Food and Drug Administration (FDA) clearance for its Solus Gold Embolization Device, a next-generation product for peripheral vascular occlusion.

Thus, the factors mentioned above are going to positively drive the North America transcatheter embolization and occlusion devices market forward during the forecast period.

Transcatheter Embolization and Occlusion Devices Market Key Players:

Some of the key market players operating in the transcatheter embolization and occlusion devices market include Boston Scientific Corporation, Medtronic PLC, Penumbra, Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Merit Medical Systems, Inc., Johnson & Johnson Services, Inc., Lepu Medical Technology(Beijing)Co., Ltd., Kaneka Medix Corporation, Stryker Corporation, phenox GmbH, Braile Biomedica, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., and others.

Recent Developmental Activities in the Transcatheter Embolization and Occlusion Devices Market:

In April 2022, Medtronic plc announced it has received approval from the United States Food and Drug Administration (FDA) for Pipeline(TM) Flex Embolization Device with Shield Technology(TM). Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device which demonstrates the reduction in material thrombogenicity, a reduction in the tendency of the surface treatment material to create clots.

In March 2022, The US Food and Drug Administration (FDA) cleared Boston Scientific's TheraSphere Y-90 Glass Microspheres, an interventional radiology therapy developed for the transcatheter treatment of patients with hepatocellular carcinoma (HCC).

In August 2020, Stryker announced that it has received US Food and Drug Administration (FDA) approval for an expanded indication of its Neuroform Atlas Stent System, becoming the first and only adjunctive stent approved for use in the posterior (back of the brain) circulation. The Neuroform Atlas Stent System is indicated for use with neurovascular embolization coils in the anterior and posterior circulation of the neurovasculature for endovascular treatment.

Key Takeaways from the Transcatheter Embolization and Occlusion Devices Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Transcatheter Embolization and Occlusion Devices market.

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global transcatheter embolization and occlusion devices market.

Various opportunities are available for the other competitor in the transcatheter embolization and occlusion devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030?

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for transcatheter embolization and occlusion devices market growth in the coming future?

Target Audience who can be benefited from this transcatheter embolization and occlusion devices market ket report study

Transcatheter Embolization and Occlusion Devices providers

Research organizations and consulting companies

Transcatheter Embolization and Occlusion Devices related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in transcatheter embolization and occlusion devices

Various End-Users want to know more about the transcatheter embolization and occlusion devices market and the latest technological developments in the transcatheter embolization and occlusion devices market.

Frequently Asked Questions for Transcatheter Embolization and Occlusion Devices Market:

1. What are Transcatheter Embolization and Occlusion Devices?

In interventional radiology, transcatheter embolization and occlusion (TEO) is a minimally invasive (MI) treatment in which a synthetic embolus is positioned or implanted into the blood vessel via a fine catheter to block the flow of blood to the tumor or other areas of the body.

2. What is the market for global transcatheter embolization and occlusion devices?

The global transcatheter embolization and occlusion devices market was valued at USD 4.04 billion in 2023, growing at a CAGR of 9.14% during the forecast period from 2024 to 2030, to reach USD 6.84 billion by 2030.

3. What are the drivers for the global transcatheter embolization and occlusion devices market?

The major drivers driving the demand for transcatheter embolization and occlusion devices are rising technological advancement, a surge in the incidence of cardiovascular diseases, respiratory disorders, and cancer, a highly structured healthcare industry, increased adoption of minimally invasive surgeries, and an increasing geriatric population among others.

4. Who are the key players operating in global transcatheter embolization and occlusion devices?

Some of the key market players operating in the transcatheter embolization and occlusion devices market include Boston Scientific Corporation, Medtronic PLC, Penumbra, Inc., Cook Medical Inc., Edwards Lifesciences Corporation, Merit Medical Systems, Inc., Johnson & Johnson Services, Inc., Lepu Medical Technology(Beijing)Co., Ltd., Kaneka Medix Corporation, Stryker Corporation, phenox GmbH, Braile Biomedica, Terumo Corporation, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., and others.

5. Which region has the highest share in the transcatheter embolization and occlusion devices market?

North America is expected to dominate the overall transcatheter embolization and occlusion devices market during the forecast period, 2024 to 2030. This domination is due to the improved reimbursement policies, easy accessibility, and high adoption of technological advancements owing to the rise in healthcare expenditure by the US government.

Table of Contents

1. Transcatheter Embolization and Occlusion Devices Market Report Introduction

2. Transcatheter Embolization and Occlusion Devices Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Transcatheter Embolization and Occlusion Devices Market Key Factors Analysis

  • 4.1. Transcatheter Embolization and Occlusion Devices Market Drivers
    • 4.1.1. Increasing incidence of chronic diseases
    • 4.1.2. Integration of advanced technology
    • 4.1.3. The rise in the investments, and funds by public-private organizations
    • 4.1.4. Increasing geriatric population
  • 4.2. Transcatheter Embolization and Occlusion Devices Market Restraints and Challenges
    • 4.2.1. High cost of the devices
    • 4.2.2. Requirement of skilled physicians
  • 4.3. Transcatheter Embolization and Occlusion Devices Market Opportunities
    • 4.3.1. Preference for minimally invasive devices
    • 4.3.2. Growth opportunities in emerging countries

5. Transcatheter Embolization and Occlusion Devices Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Transcatheter Embolization and Occlusion Devices Market layout

  • 6.1. By Type
    • 6.1.1. Coiled
      • 6.1.1.1. Pushable Coils
      • 6.1.1.2. Detachable Coils
    • 6.1.2. Non-Coiled
      • 6.1.2.1. Flow Diverting Devices
      • 6.1.2.2. Embolization Particles
      • 6.1.2.3. Liquid Embolic
      • 6.1.2.4. Others
  • 6.2. By Application
    • 6.2.1. Peripheral Vascular Disease
    • 6.2.2. Oncology
    • 6.2.3. Neurology
    • 6.2.4. Urology
    • 6.2.5. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Clinics
  • 6.4. By Geography
    • 6.4.1. North America Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.1. United States Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.2. Canada Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.1.3. Mexico Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.2. Europe Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.1. France Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.2. Germany Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.3. United Kingdom Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.4. Italy Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.5. Spain Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.2.6. Rest of Europe Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.3. Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.1. China Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.2. Japan Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.3. India Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.4. Australia Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.5. South Korea Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.3.6. Rest of Asia-Pacific Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
    • 6.4.4. Rest of the World (RoW) Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.1. Middle East Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.2. Africa Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)
      • 6.4.4.3. South America Transcatheter Embolization and Occlusion Devices Market Size in USD million (2021-2030)

7. Transcatheter Embolization and Occlusion Devices Company and Product Profiles

  • 7.1. Boston Scientific Corporation
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Medtronic PLC
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Penumbra, Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Cook Medical Inc.
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Edwards Lifesciences Corporation
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Merit Medical Systems, Inc.
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Johnson & Johnson Services, Inc.
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. Lepu Medical Technology(Beijing)Co., Ltd.
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Kaneka Medix Corporation
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Stryker Corporation
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. phenox GmbH
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. Braile Biomedica
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Terumo Corporation
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. MicroPort Scientific Corporation
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. W. L. Gore & Associates, Inc.
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy

8. KOL Views

9. Project Approach

10. DelveInsight Capabilities

11. About DelveInsight

12. Disclaimer & Contact Us